| Industry Range | | Price / Earnings | N/A | |
| Book Value | 0.82 | |
| Earnings Per Share | -$0.98 | |
| Price To Sales Ratio | 1.76 | |
| Price To Book Ratio | 1.62 | |
| Price To Tangible Book Ratio | 2.37 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 71.8M | |
| Float (MRQ) | 79.67% | |
| Shares Outstanding (MRQ) | 89.4M | |
| Short Interest as a % of Float (MRQ) | 0.79% | |
| Shares Held By Institutions (MRQ) | 30.3M | |
| Industry Range | | Sales | $77.6M | |
| Gross Margin | 54.10% | |
| Net Profit Margin | -117.49% | |
| EBIT Margin | -271.77% | |
| EBITDA Margin | -260.89% | |
| Operating Margins | -271.77% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 3.43 | |
| Quick Ratio (MRQ) | 3.33 | |
| Total Debt/Equity Ratio (MRQ) | 203.35 | |
| Debt/Common Equity Ratio (MRQ) | 203.36 | |
| Industry Range | | Return on Equity | -105.60% | |
| Return on Assets | -29.31% | |
| Asset Turnover | 0.25 | |
| Receivables Turnover | 2.78 | |
| Inventory Turnover | 2.49 | |
| Industry Range | | EPS Growth Annual | 123.40% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*FBIO does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.00%